Advaxis, Inc. (NASDAQ:ADXS) marched up 63.76% compared to a 52-week low price of $0.18. The shares were last seen trading -15.56% lower, taking the closing price at $0.3 on 01/11/2019. At recent session, the prices were hovering between $0.2936 and $0.346. This company shares are 733.33% off its target price of $2.5 and the current market capitalization stands at $24.33M. The recent change has given its price a -25.03% deficit over SMA 50 and -91% deficit over its 52-week high. The stock witnessed -17.8% declines, -62.85% declines and -75.7% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found ADXS’s volatility during a week at 29.32% and during a month it has been found around 19.08%.Advaxis, Inc. (ADXS) Top Holders
Institutional investors currently hold around $5 million or 24.3% in ADXS stock. Look at its top three institutional owners. Cvi Holdings, Llc owns $1.02 million in Advaxis, Inc., which represents roughly 4.18% of the company’s market cap and approximately 20.36% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 2,630,658 shares of the stock are valued at $779 thousand. The third largest holder is Adage Capital Partners Gp, L.L.C., which currently holds $740 thousand worth of this stock and that ownership represents nearly 3.04% of its market capitalization.Advaxis, Inc. 13F Filings
At the end of September reporting period, 23 institutional holders increased their position in Advaxis, Inc. (NASDAQ:ADXS) by some 6,582,683 shares, 32 decreased positions by 2,205,417 and 20 held positions by 6,955,581. That puts total institutional holdings at 15,743,681 shares, according to SEC filings. The stock grabbed 10 new institutional investments totaling 3,659,730 shares while 13 institutional investors sold out their entire positions totaling 667,518 shares.Advaxis, Inc. (NASDAQ:ADXS) Insider Trades
Multiple company employees have indulged in significant insider trading. Advaxis, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Chief Scientific Officer Petit Robert has sold 3,963 shares of Advaxis, Inc. (ADXS) in trading session dated Nov. 05, 2018. These shares are worth $2,299 and were traded at $0.58 each. The SEC filing shows that Petit Robert performed a sale of 8,491 shares. The Chief Scientific Officer disposed these shares by way of transaction on Nov. 02, 2018. The company’s shares were given away at $0.56 per share worth to an income of some $4,755 on account of Petit Robert.
Director, Appel Roni, purchased 33,333 common shares of Advaxis, Inc. (ADXS) in the open market. In a transaction dated Sep. 11, 2018, the shares were bought at an average price of $1.2, giving away a sum of $40,000. After this purchase, 157,143 common shares of ADXS are directly owned by the insider, with total stake valued at $47,143.
In the transaction dated Apr. 02, 2018, the great number of shares disposed came courtesy the Chief Scientific Officer; Petit Robert disposed a total of 2,193 shares at an average price of $1.62, amounting to approximately $3,553. The insider now directly owns 223,500 shares worth $67,050.Advaxis, Inc. (ADXS) Analyst Guide
Several analysts have released their opinion on Advaxis, Inc. (NASDAQ:ADXS), with 0 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 2 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.33 average brokerage recommendation.